Edition:
United States

Melinta Therapeutics, Inc. (MLNT.OQ)

MLNT.OQ on NASDAQ Stock Exchange Global Select Market

14.80USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$14.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
32,406
52-wk High
$39.12
52-wk Low
$10.50

Chart for

About

Melinta Therapeutics, Inc., formerly Cempra, Inc., is a clinical-stage pharmaceutical company. The Company focuses on developing differentiated antibiotics for the acute care and community settings to meet medical needs in the treatment of bacterial infectious diseases. Its product, solithromycin (CEM-101), which is a macrolide... (more)

Overall

Beta: 1.16
Market Cap(Mil.): $155.44
Shares Outstanding(Mil.): 10.50
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 188.50 15.25
EPS (TTM): -- -- --
ROI: -- -11.67 33.27
ROE: -- -36.21 16.35

BRIEF-Medicines Company Announces Definitive Agreement To Sell Its Infectious Disease Business Unit To Melinta Therapeutics

* THE MEDICINES COMPANY ANNOUNCES DEFINITIVE AGREEMENT TO SELL ITS INFECTIOUS DISEASE BUSINESS UNIT TO MELINTA THERAPEUTICS

Nov 29 2017

BRIEF-Melinta Therapeutics Enters Agreement To Acquire Infectious Disease Business From The Medicines Company

* MELINTA THERAPEUTICS ENTERS INTO AGREEMENT TO ACQUIRE INFECTIOUS DISEASE BUSINESS FROM THE MEDICINES COMPANY Source text for Eikon: Further company coverage:

Nov 29 2017

Competitors

  Price Chg
Astellas Pharma Inc (4503.T) ¥1,445 +3.00
Johnson & Johnson (JNJ.N) $142.60 --
Pfizer Inc. (PFE.N) $36.58 --
Roche Holding Ltd. (ROG.S) CHF241.30 -0.40
Roche Holding Ltd. (RO.S) CHF243.70 -0.30
Abbott Laboratories (ABT.N) $55.70 --
Bayer AG (BAYGn.DE) €106.55 -0.10
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €74.77 -0.26
AstraZeneca plc (AZN.L) 4,909.00 -26.00

Earnings vs. Estimates